Table 2 A comparison between the athletes that participated in the follow-up and those that did not
Follow-up, n = 29 | No follow-up, n = 69 | All, n = 98 | P-value | |
|---|---|---|---|---|
Males | 14 (48%) | 33 (47%) | 47 (48%) | 0.918 |
Age, median (quartile 1-quartile 3) | 18 (17–19) | 18 (17–21) | 17 (18–20) | 0.568 |
EID | 11 (38%) | 20 (29%) | 30 (31%) | 0.361 |
Physician-diagnosed asthma | 12 (41%) | 28 (40%) | 40 (41%) | 0.899 |
Current use of asthma medication | 10 (34%) | 22 (31%) | 32 (33%) | 0.767 |
EILO | 11 (38%) | 16 (23%) | 26 (28%) | 0.170 |
Supraglottic | 11 (38%) | 16 (23%) | 27 (28%) | |
Glottic | 0 (0) | 0 (0) | 0 (0) | |
Borg RPE | 16 (16–16.5) | 17 (16–17) | 16.75 (16–17) |